The TyeeOpinion

This Physicist Says We Don’t Take COVID Seriously Enough

Last month Neil Sprackling, a CEO with Swiss Re, cited long COVID as a significant factor contributing to that two per cent ...
Le Lézard

Nefecon Included in the Updated KDIGO Clinical Practice Guideline, Strengthening Asahi Kasei's Position in IgA Nephropathy Treatment

Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonide) delayed release capsules), has been included ...
Le Lézard

Calliditas Therapeutics to Present at the American Society of Nephrology Kidney Week

Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data will be presented at the 2025 American Society of Nephrology Kidney Week, taking place from November 6 to 9 ...
FMIBlog

Superficial Radiation Therapy System Market Set to Reach USD 70.3 Billion by 2035: Growth Driven by Technological Innovations

System Market is projected to witness significant growth over the next decade, with market value estimated at USD 48.4 ...
Barron's

Paul R. La Monica

The S&P 1500 is dominated by Big Tech just like the S&P 500. But small-caps are having a moment, and their rally could have real legs. Copper prices are up this year but they’ve lagged the spike in ...